Loading…
Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial
Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behavi...
Saved in:
Published in: | The American heart journal 2015-09, Vol.170 (3), p.430-437.e9 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633 |
---|---|
cites | cdi_FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633 |
container_end_page | 437.e9 |
container_issue | 3 |
container_start_page | 430 |
container_title | The American heart journal |
container_volume | 170 |
creator | Gianos, Eugenia, MD Schoenthaler, Antoinette, EdD, MA Mushailov, Michael, MS Fisher, Edward A., MD, PhD Berger, Jeffrey S., MD, MS |
description | Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behaviors. Design The IMPACT trial is a 400-subject prospective randomized trial designed to compare different cardiovascular prevention strategies in subjects following a cardiovascular intervention. The trial began enrollment in the Spring of 2012 and is randomizing subjects in a 1:1:1 manner to usual care, a one-time cardiovascular prevention consult, or a one-time cardiovascular prevention consult plus behavioral intervention program (telephone-based motivational interviewing and tailored text messages) over a 6-month period. The primary end point is non–high-density lipoprotein cholesterol. Secondary end points include other plasma lipid values, metabolic risk, smoking cessation, physical activity, dietary intake, medication use and adherence, and quality of life. Conclusions The IMPACT trial provides data on different management strategies for risk factor optimization in subjects following cardiovascular procedures. The results will provide a platform for the continued development of novel multidisciplinary interventions in this high-risk population. |
doi_str_mv | 10.1016/j.ahj.2015.06.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1713948254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870315003683</els_id><sourcerecordid>3807018211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxiMEotvCA3BBlriUQ8LYTpxESEiriD8rtaKC5Ww5zmTXSzZu7SSoT9FXxtldQOqBkzWe3zfSfN9E0SsKCQUq3u0Std0lDGiWgEgA6JNoQaHMY5Gn6dNoAQAsLnLgZ9G597tQClaI59EZE7zIgGWL6OGbGoztVYdE9Q1p0JtNT2xLhi2SVT-hH8zmgMyf13Yw00kQugO6yeAv028O4huHE_YHtrK9H7vBk8GSpd6a0CCVco2xk_J67JQja-U2GIjL1fXNslq_JYMzqnsRPWtV5_Hl6b2Ifnz6uK6-xFdfP6-q5VWsMxBDXCNjSoiWYoNFDQUHXhZMNYozhmUKtShbjSJDSmultOZ5puq61pyXtS4F5xfR5XHurbN3Y9hS7o3X2HWqRzt6SXPKy7RgWRrQN4_QnR1dcOBAMZ6mwflA0SOlnfXeYStvndkrdy8pyDktuZMhLTmnJUHIo-b1afJY77H5q_gTTwDeHwEMVgSrnfTaYK-xMQ71IBtr_jv-wyO17kxvtOp-4j36f1tIzyTI7_O5zNdCMwAuCs5_A4oDu0c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1712344001</pqid></control><display><type>article</type><title>Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Gianos, Eugenia, MD ; Schoenthaler, Antoinette, EdD, MA ; Mushailov, Michael, MS ; Fisher, Edward A., MD, PhD ; Berger, Jeffrey S., MD, MS</creator><creatorcontrib>Gianos, Eugenia, MD ; Schoenthaler, Antoinette, EdD, MA ; Mushailov, Michael, MS ; Fisher, Edward A., MD, PhD ; Berger, Jeffrey S., MD, MS</creatorcontrib><description>Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behaviors. Design The IMPACT trial is a 400-subject prospective randomized trial designed to compare different cardiovascular prevention strategies in subjects following a cardiovascular intervention. The trial began enrollment in the Spring of 2012 and is randomizing subjects in a 1:1:1 manner to usual care, a one-time cardiovascular prevention consult, or a one-time cardiovascular prevention consult plus behavioral intervention program (telephone-based motivational interviewing and tailored text messages) over a 6-month period. The primary end point is non–high-density lipoprotein cholesterol. Secondary end points include other plasma lipid values, metabolic risk, smoking cessation, physical activity, dietary intake, medication use and adherence, and quality of life. Conclusions The IMPACT trial provides data on different management strategies for risk factor optimization in subjects following cardiovascular procedures. The results will provide a platform for the continued development of novel multidisciplinary interventions in this high-risk population.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2015.06.001</identifier><identifier>PMID: 26385025</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Blood pressure ; Cardiology ; Cardiovascular ; Cardiovascular Diseases - prevention & control ; Cholesterol ; Diabetes ; Disease Management ; Disease prevention ; Education ; Family medical history ; Female ; Health risk assessment ; Heart attacks ; Humans ; Hypertension ; Informed consent ; Intubation ; Lifestyles ; Male ; Middle Aged ; Motivational Interviewing - organization & administration ; Nutrition research ; Prospective Studies ; Randomized Controlled Trials as Topic - methods ; Smoking cessation ; United States</subject><ispartof>The American heart journal, 2015-09, Vol.170 (3), p.430-437.e9</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633</citedby><cites>FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26385025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gianos, Eugenia, MD</creatorcontrib><creatorcontrib>Schoenthaler, Antoinette, EdD, MA</creatorcontrib><creatorcontrib>Mushailov, Michael, MS</creatorcontrib><creatorcontrib>Fisher, Edward A., MD, PhD</creatorcontrib><creatorcontrib>Berger, Jeffrey S., MD, MS</creatorcontrib><title>Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behaviors. Design The IMPACT trial is a 400-subject prospective randomized trial designed to compare different cardiovascular prevention strategies in subjects following a cardiovascular intervention. The trial began enrollment in the Spring of 2012 and is randomizing subjects in a 1:1:1 manner to usual care, a one-time cardiovascular prevention consult, or a one-time cardiovascular prevention consult plus behavioral intervention program (telephone-based motivational interviewing and tailored text messages) over a 6-month period. The primary end point is non–high-density lipoprotein cholesterol. Secondary end points include other plasma lipid values, metabolic risk, smoking cessation, physical activity, dietary intake, medication use and adherence, and quality of life. Conclusions The IMPACT trial provides data on different management strategies for risk factor optimization in subjects following cardiovascular procedures. The results will provide a platform for the continued development of novel multidisciplinary interventions in this high-risk population.</description><subject>Blood pressure</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Cholesterol</subject><subject>Diabetes</subject><subject>Disease Management</subject><subject>Disease prevention</subject><subject>Education</subject><subject>Family medical history</subject><subject>Female</subject><subject>Health risk assessment</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Informed consent</subject><subject>Intubation</subject><subject>Lifestyles</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motivational Interviewing - organization & administration</subject><subject>Nutrition research</subject><subject>Prospective Studies</subject><subject>Randomized Controlled Trials as Topic - methods</subject><subject>Smoking cessation</subject><subject>United States</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9ks9u1DAQxiMEotvCA3BBlriUQ8LYTpxESEiriD8rtaKC5Ww5zmTXSzZu7SSoT9FXxtldQOqBkzWe3zfSfN9E0SsKCQUq3u0Std0lDGiWgEgA6JNoQaHMY5Gn6dNoAQAsLnLgZ9G597tQClaI59EZE7zIgGWL6OGbGoztVYdE9Q1p0JtNT2xLhi2SVT-hH8zmgMyf13Yw00kQugO6yeAv028O4huHE_YHtrK9H7vBk8GSpd6a0CCVco2xk_J67JQja-U2GIjL1fXNslq_JYMzqnsRPWtV5_Hl6b2Ifnz6uK6-xFdfP6-q5VWsMxBDXCNjSoiWYoNFDQUHXhZMNYozhmUKtShbjSJDSmultOZ5puq61pyXtS4F5xfR5XHurbN3Y9hS7o3X2HWqRzt6SXPKy7RgWRrQN4_QnR1dcOBAMZ6mwflA0SOlnfXeYStvndkrdy8pyDktuZMhLTmnJUHIo-b1afJY77H5q_gTTwDeHwEMVgSrnfTaYK-xMQ71IBtr_jv-wyO17kxvtOp-4j36f1tIzyTI7_O5zNdCMwAuCs5_A4oDu0c</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Gianos, Eugenia, MD</creator><creator>Schoenthaler, Antoinette, EdD, MA</creator><creator>Mushailov, Michael, MS</creator><creator>Fisher, Edward A., MD, PhD</creator><creator>Berger, Jeffrey S., MD, MS</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150901</creationdate><title>Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial</title><author>Gianos, Eugenia, MD ; Schoenthaler, Antoinette, EdD, MA ; Mushailov, Michael, MS ; Fisher, Edward A., MD, PhD ; Berger, Jeffrey S., MD, MS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Blood pressure</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Cholesterol</topic><topic>Diabetes</topic><topic>Disease Management</topic><topic>Disease prevention</topic><topic>Education</topic><topic>Family medical history</topic><topic>Female</topic><topic>Health risk assessment</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Informed consent</topic><topic>Intubation</topic><topic>Lifestyles</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motivational Interviewing - organization & administration</topic><topic>Nutrition research</topic><topic>Prospective Studies</topic><topic>Randomized Controlled Trials as Topic - methods</topic><topic>Smoking cessation</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gianos, Eugenia, MD</creatorcontrib><creatorcontrib>Schoenthaler, Antoinette, EdD, MA</creatorcontrib><creatorcontrib>Mushailov, Michael, MS</creatorcontrib><creatorcontrib>Fisher, Edward A., MD, PhD</creatorcontrib><creatorcontrib>Berger, Jeffrey S., MD, MS</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Health Management Database (Proquest)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gianos, Eugenia, MD</au><au>Schoenthaler, Antoinette, EdD, MA</au><au>Mushailov, Michael, MS</au><au>Fisher, Edward A., MD, PhD</au><au>Berger, Jeffrey S., MD, MS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>170</volume><issue>3</issue><spage>430</spage><epage>437.e9</epage><pages>430-437.e9</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-News-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><abstract>Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behaviors. Design The IMPACT trial is a 400-subject prospective randomized trial designed to compare different cardiovascular prevention strategies in subjects following a cardiovascular intervention. The trial began enrollment in the Spring of 2012 and is randomizing subjects in a 1:1:1 manner to usual care, a one-time cardiovascular prevention consult, or a one-time cardiovascular prevention consult plus behavioral intervention program (telephone-based motivational interviewing and tailored text messages) over a 6-month period. The primary end point is non–high-density lipoprotein cholesterol. Secondary end points include other plasma lipid values, metabolic risk, smoking cessation, physical activity, dietary intake, medication use and adherence, and quality of life. Conclusions The IMPACT trial provides data on different management strategies for risk factor optimization in subjects following cardiovascular procedures. The results will provide a platform for the continued development of novel multidisciplinary interventions in this high-risk population.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26385025</pmid><doi>10.1016/j.ahj.2015.06.001</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 2015-09, Vol.170 (3), p.430-437.e9 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_1713948254 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Blood pressure Cardiology Cardiovascular Cardiovascular Diseases - prevention & control Cholesterol Diabetes Disease Management Disease prevention Education Family medical history Female Health risk assessment Heart attacks Humans Hypertension Informed consent Intubation Lifestyles Male Middle Aged Motivational Interviewing - organization & administration Nutrition research Prospective Studies Randomized Controlled Trials as Topic - methods Smoking cessation United States |
title | Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T07%3A43%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rationale%20and%20design%20of%20the%20Investigation%20of%20Motivational%20Interviewing%20and%20Prevention%20Consults%20to%20Achieve%20Cardiovascular%20Targets%20(IMPACT)%20trial&rft.jtitle=The%20American%20heart%20journal&rft.au=Gianos,%20Eugenia,%20MD&rft.date=2015-09-01&rft.volume=170&rft.issue=3&rft.spage=430&rft.epage=437.e9&rft.pages=430-437.e9&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2015.06.001&rft_dat=%3Cproquest_cross%3E3807018211%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c506t-be22a66f1ede8b08303982ada322e940b69fce65e11baacc375abbbc339bc9633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1712344001&rft_id=info:pmid/26385025&rfr_iscdi=true |